American Journal of Ophthalmology
Volume 136, Issue 1 , Pages 47-54, July 2003

Mortality after deferral of treatment or no treatment for choroidal melanoma☆

  • Bradley R Straatsma, MD

      Affiliations

    • Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles (B.R.S., R.C., R.E.E.), Los Angeles, California, USA
    • Corresponding Author InformationInquiries to Bradley R. Straatsma, MD, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, 100 Stein Plaza, UCLA, Los Angeles, CA, USA 90095-7000; fax: (310) 206-4293.
    • ,
  • Marie Diener-West, PhD

      Affiliations

    • Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University (M.D.-W.), Baltimore, Maryland, USA
    • ,
  • Robert Caldwell, PA

      Affiliations

    • Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles (B.R.S., R.C., R.E.E.), Los Angeles, California, USA
    • ,
  • Robert E Engstrom Jr, MD

      Affiliations

    • Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at University of California Los Angeles (B.R.S., R.C., R.E.E.), Los Angeles, California, USA
    • ,
  • For The Collaborative Ocular Melanoma Study Group

      Affiliations

    • A complete listing of the Collaborative Ocular Melanoma Study (COMS) group is available in The American Journal of Ophthalmology 1998;125:757–765.

Accepted 23 December 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported by the National Eye Institute and the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, and Research to Prevent Blindness, New York, New York.

PII: S0002-9394(02)02270-5

doi:10.1016/S0002-9394(02)02270-5

American Journal of Ophthalmology
Volume 136, Issue 1 , Pages 47-54, July 2003

Article Tools

* Image Usage & Resolution